Stay updated on Nivolumab vs Docetaxel in NSCLC: Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Docetaxel in NSCLC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Docetaxel in NSCLC: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Site revision label updated from v3.4.2 to v3.4.3 in the footer; no changes to study content or data.
    Difference
    0.0%
    Check dated 2026-03-12T02:25:09.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The changes are minor version-tag updates: Revision: v3.4.2 added and Revision: v3.4.1 removed; no impact on study content or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T11:25:46.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Added a site-wide funding-status notice indicating possible data delays and directing users to cc.nih.gov and opm.gov, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T06:47:53.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Show glossary and updated metadata (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) were added and older metadata (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4) were removed.
    Difference
    0.2%
    Check dated 2026-01-28T04:20:32.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page; this is a minor metadata update with no changes to study content, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:42:03.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The study location sections were consolidated under a single 'Locations' heading and list the regions (Beijing Municipality, Chongqing Municipality, Fujian, Guangdong, Henan, Hunan, Jiangsu, Jilin, Shanghai Municipality, Sichuan, Zhejiang). The previous per-location 'X Locations' subsections were removed and a revision note (Revision: v3.3.3) was added.
    Difference
    1%
    Check dated 2025-12-23T21:06:52.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Docetaxel in NSCLC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Docetaxel in NSCLC: Clinical Trial page.